Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Ann Surg Oncol. 2018 Nov 30;26(2):336–342. doi: 10.1245/s10434-018-7004-6

FIG. 1.

FIG. 1

Management of pre-NAC cN+ patients. NAC neoadjuvant chemotherapy, cN+ clinically node-positive, pts patients, SLN sentinel lymph node, ALND axillary lymph node dissection, ypN0 node negative on final surgical pathology, ypN+ node positive on final surgical pathology